Grand Hopital de Charleroi asbl

Charleroi 6000

1 studies enrolling now · 5 studies all time

What they study most

Early Breast Cancer, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Multiple Myeloma, Myelodysplastic Syndromes, Pancreatic Cancer Metastatic, Pancreatic Cancer Stage IV, Pancreatic Ductal Adenocarcinoma, Solid Tumors

Studies at this site

• Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer — Recruiting now
• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers — Running, not enrolling
• An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants — Stopped early
• An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML) — Completed